Finanical Statements
Egyptian International Pharmaceuticals (EIPICO) (PHAR.CA) Reports its Financial Results (Standalone) for the Period from 01/01/2026 to 30/06/2026
Published at 16 August 2026 at 06:16Egyptian International Pharmaceuticals (EIPICO)Related stock:Egyptian International Pharmaceuticals (EIPICO) stockAll Egyptian International Pharmaceuticals (EIPICO) disclosures
Disclosure summary
Company Name: Egyptian International Pharmaceuticals (EIPICO)
ISIN Code: EGS38081C013
Currency: Egyptian Pound
F/S (Standalone) Period: From 01/01/2026 to 30/06/2026
Net profit: 433,403,500
F/S (Standalone) Period: From 01/01/2025 to 30/06/2025
Net Comparative profit: 606,543,699
Audit Status: Reviewed
Source: Egyptian International Pharmaceuticals (EIPICO)
The BoD Report in English (199 KB)
The Financial Statements in Arabic (1,573 KB)
The BoD Report in Arabic (146 KB)
The Financial Statements in English (3,358 KB)
ISIN Code: EGS38081C013
Currency: Egyptian Pound
F/S (Standalone) Period: From 01/01/2026 to 30/06/2026
Net profit: 433,403,500
F/S (Standalone) Period: From 01/01/2025 to 30/06/2025
Net Comparative profit: 606,543,699
Audit Status: Reviewed
Source: Egyptian International Pharmaceuticals (EIPICO)
The BoD Report in English (199 KB)
The Financial Statements in Arabic (1,573 KB)
The BoD Report in Arabic (146 KB)
The Financial Statements in English (3,358 KB)